Select Clinical Trial
GOG 286B: A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
- Women, ages 18 years or older, with stage III, IVA, or IVB or recurrent endometrial cancer. For additional criteria, call our Clinical Trials office at (910) 715-2200.
NRG-GY004 - Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Female, age 18 or older, diagnosed with platinum-sensitive recurrent high-grade serous or high-grade endometrioid ovarian, primary peritoneal, or fallopian tube cancers.
- For additional criteria, call our Clinical Trials office at (910) 715-2200